Current stock page

Financial Data

ALMS Financial Data

Revenue · Earnings · Margins · Balance Sheet · Cash Flow

HealthcareBiotechnologyScore data as of Nov 13, 2026

ALMSAlumis Inc.

Healthcare / Biotechnology

Low Priority

Relative Laggard

Very BearishEdge 2/10
$5.60−$0.53 (−8.65%)

Latest quote

  • Momentum
    13
  • Value
    —
  • Quality
    29
  • Risk resilience
    20
  • Sentiment
    —
algovestiq.comScore data as of Nov 13, 2026

Financial Data Overview

Detailed revenue, earnings, margins, balance sheet, cash flow, valuation metrics, technical indicators, and risk measures for deeper research.

Quarterly periods
8
Fundamental metrics
10
Technical indicators
12
Risk measures
6

Quarterly Financial Statements

Updated Nov 16, 2026.

Income statement
8 periods
Metric2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Revenue$1.91M$1.66M$1.74M$1.93M$2.07M$2.67M$17.39M$0
Gross Profit$1.91M$1.66M$870K$1.93M$2.07M$2.67M$17.39M-$820K
Operating Income-$99.08M-$148.86M-$98.41M-$96.45M-$115.29M-$140.54M-$101.53M-$98.62M
Net Income-$94.88M-$142.22M-$93.05M-$92.93M-$110.75M$59.32M-$98.96M-$94.76M
EPS-$0.73-$1.11-$0.74-$0.89-$1.06$0.78-$1.82-$1.74
Cash flow statement
8 periods
Metric2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Operating Cash Flow-$79.57M-$81.5M-$87.08M-$71.91M-$110.91M-$106.35M-$80.36M-$74.76M
Capital Expenditure-$464K-$237K-$164K$0$0-$616K-$37K-$366K
Free Cash Flow-$80.04M-$81.74M-$87.25M-$71.91M-$110.91M-$106.97M-$80.39M-$75.13M
Net Cash Provided By Operating Activities-$79.57M-$81.5M-$87.08M-$71.91M-$110.91M-$106.35M-$80.36M-$74.76M
Balance sheet
8 periods
Metric2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Total Assets$488.71M$560.62M$671.59M$411.94M$488.01M$610.93M$261.3M$340.99M
Total Debt$35.31M$36.43M$35.66M$36.91M$37.8M$38.78M$31.88M$30.72M
Cash And Cash Equivalents$57.69M$63.71M$63.89M$89.67M$65.26M$151.75M$128.54M$169.53M
Total Liabilities$110.29M$108.46M$104.57M$110.64M$103.24M$125.6M$92.98M$80.89M
Total Stockholders Equity$378.43M$452.16M$567.02M$301.3M$384.77M$485.33M$168.31M$260.1M
Key financial metrics
8 periods
Metric2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
P/E ratio————————
P/B ratio1.916.895.438.821.430.71.45—
P/S ratio100.02———————
Debt To Equity0.090.080.060.120.10.080.190.12
Free Cash Flow Yield-44.32%-11.29%-12.24%-13.93%-67.93%-102.45%-119.60%—
Financial ratios
8 periods
Metric2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
P/E ratio————————
P/B ratio1.916.895.438.821.430.71.45—
P/S ratio100.02———————
Return On Equity-111.80%-97.08%-41.87%-80.76%-63.71%-46.88%-203.99%-113.12%
Debt To Equity0.090.080.060.120.10.080.190.12

Current Stock Metrics

Current fundamental, technical, and risk readings in one place.

Fundamental metrics
MetricValue
Pe-1.61x
Pb1.91x
Revenue Growth Yoy-7.70%
EPS Growth Yoy31.13%
Gross Margin-1307.02%
Operating Margin-6116.66%
ROE-99.61%
ROIC-106.42%
Debt To Equity0.09
FCF Yield-44.28%

As of Nov 13, 2026

Technical indicators
MetricValue
Close$5.60
Volume1.49M
RSI (14)34.04
MACD-0.56
MACD signal-0.67
MACD histogram0.11
ADX (14)40.5
SMA (50)$7.24
SMA (200)$20.44
ATR (14)$0.50
Historical volatility (annualized)82.50%
Volume (20-day average)1.79M

As of Nov 13, 2026

Risk measures
MetricValue
Resilience score20/100
Beta1.98
Annual volatility137.60%
Max Drawdown-81.52%
Sharpe Ratio0.65
VaR (95%, 1-day)-7.39%

As of Nov 13, 2026

Detailed Metrics

Additional measures remain available here while the decision pages stay focused.

Additional fundamental metrics

No additional fundamental metrics are available.

Additional technical indicators

No additional technical indicators are available.

Additional risk measures

No additional risk measures are available.

ALMS Financial Data FAQ

What is Alumis Inc.'s revenue?

Alumis Inc.'s revenue is one of the core financial data points for ALMS. Use it with revenue growth, margins, and EPS to understand whether sales are translating into earnings power.

Is Alumis Inc.'s revenue growing?

Revenue growth shows whether Alumis Inc. is expanding from prior periods. Compare growth with margins and free cash flow because faster sales growth is more valuable when profitability holds up.

What is ALMS's EPS?

ALMS's EPS, or earnings per share, helps connect net income to each share. EPS should be compared with EPS growth, P/E ratio, and analyst expectations.

What is Alumis Inc.'s net income?

Alumis Inc.'s net income shows profit after costs, taxes, and other expenses. It should be read with revenue, operating margin, EPS, and free cash flow.

How much free cash flow does Alumis Inc. generate?

Free cash flow shows how much cash Alumis Inc. generates after capital spending. It is useful for judging reinvestment capacity, buybacks, debt reduction, and valuation support.

How much cash and debt does Alumis Inc. have?

Cash and debt help frame ALMS's balance-sheet flexibility. Compare liquidity and leverage with free cash flow and profitability before judging financial strength.